CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Planned sale VP Finance & Operations sold 464 shares at an average $0.58 ($269)
- 4 Planned sale President and CEO sold 5,922 shares at an average $0.55 ($3,248)
- 4 Planned sale VP Finance & Operations sold 464 shares at an average $0.65 ($299)
- 4 Planned sale President and CEO sold 5,628 shares at an average $0.64 ($3,604)
- 4 Planned sale VP Finance & Operations sold 466 shares at an average $0.64 ($301)
- 4 Planned sale President and CEO sold 5,510 shares at an average $0.65 ($3,576)
- 4 Planned sale President and CEO sold 5,523 shares at an average $0.68 ($3,728)
- 4 Planned sale VP Finance & Operations sold 487 shares at $0.64 ($312)
- 4 Planned sale President and CEO sold 5,608 shares at an average $0.68 ($3,814)
- 4 Planned sale VP Finance & Operations sold 479 shares at an average $0.67 ($319)
- 4 Planned sale President and CEO sold 5,407 shares at an average $0.68 ($3,702)
- 4 Planned sale VP Finance & Operations sold 455 shares at an average $0.68 ($310)
- 4 Planned sale President and CEO sold 5,266 shares at an average $0.56 ($2,926)
- 4 Planned sale VP Finance & Operations sold 463 shares at an average $0.53 ($243)
- 4 Planned sale President and CEO sold 5,475 shares at an average $0.49 ($2,710)
- 4 Planned sale VP Finance & Operations sold 460 shares at an average $0.49 ($225)
- 4 Planned sale VP Finance & Operations sold 450 shares at an average $0.50 ($225)
Page 7 of 18 · 354 filings